tirzepatide and hypoglycemia Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes Obesity: A Mini-Review Multiple effects of tirzepatide. |

The GIP component improves insulin sensitivity and appears to contribute to the favorable tolerability profile

However, DPP-4 inhibitors have not reduced the risk of major adverse cardiovascular events, possibly because potentiation of SDF-1 enhances plaque growth and instability, activates deleterious neurohormonal mechanisms, and promotes cardiac inflammation and fibrosis

Switching to liposomal or sublingual formulations may improve intact GSH delivery, though clinical evidence for superior outcomes remains limited

Hand Ther

BMI and weight changes BMI was calculated as body weight in kilograms divided by height in meters squared based on measurements at baseline before randomization